SCHEMBL199772

SCHEMBL199772

CC(C)c1cc(C(C)(C)C)cc(C(C)C)c1O

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
GABRA1 P14867 6/20 0.54
GABRB1 P18505 4/20 0.54
GABRB2 P47870 4/20 0.54
GAA P10253 2/20 0.48
FAAH O00519 1/20 0.46
LMNA P02545 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
GABRG2 P18507 1/20 0.46
PTGS1 P23219 1/20 0.46
SLC6A2 P23975 1/20 0.46
HTR2C P28335 1/20 0.46
GABRB3 P28472 1/20 0.46
GABRA5 P31644 1/20 0.46
GABRA3 P34903 1/20 0.46
HTR2B P41595 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15347576 0.94 CA1 (0.52) CA1CA2GABRA1GABRB1GABRB2
SCHEMBL17500114 0.89 CA1 (0.46) CA1CA2GABRA1GABRB1GABRB2
SCHEMBL27728974 0.89 GABRA1 (0.55) CA1CA2GABRA1GABRB1GABRB2
SCHEMBL8897543 0.89 CA1 (0.46) CA1CA2GABRA1GABRB1GABRB2
SCHEMBL6768184 0.87 CYP1A2 (0.57) CA1CA2GABRA1GABRB1GABRB2
SCHEMBL31593161 0.87 CYP1A2 (0.57) CA1CA2GABRA1GABRB1GABRB2
SCHEMBL31593162 0.87 CYP1A2 (0.57) CA1CA2GABRA1GABRB1GABRB2
SCHEMBL299993 0.86 CA1 (0.58) CA1CA2GABRA1GABRB1GABRB2
SCHEMBL9622193 0.86 GABRA1 (0.50) CA1CA2GABRA1GABRB1GABRB2
SCHEMBL9512821 0.86 GABRA1 (0.50) CA1CA2GABRA1GABRB1GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4013379-B1 NO STAINING ANTIPERSPIRANT COMPOSITION UNILEVER IP HOLDINGS B V (NL) 2025-01-08 EP claimed
CN-113292740-B Anti-agglomerating agent for polyisobutene production 巴斯夫东南亚有限公司 2024-10-18 CN claimed
US-20220257480-A1 AN ANTIPERSPIRANT COMPOSITION CONOPCO, INC., D/B/A UNILEVER (US) 2022-08-18 US claimed
EP-4013379-A1 AN ANTIPERSPIRANT COMPOSITION Unilever IP Holdings B.V. (NL) 2022-06-22 EP claimed
CN-113355139-A Alcohol-based fuel with high combustion value for vehicle 东奇能源技术有限公司 2021-09-07 CN claimed
CN-107075211-B Novel antiagglomerating agents for the production of polyisobutenes 巴斯夫东南亚有限公司 2021-07-30 CN claimed
WO-2021028180-A1 AN ANTIPERSPIRANT COMPOSITION UNILEVER IP HOLDINGS B.V. (NL) 2021-02-18 WO claimed
EP-3161069-B1 NOVEL ANTI-AGGLOMERANTS FOR POLYISOBUTYLENE PRODUCTION BASF SOUTH EAST ASIA PTE LTD (SG) 2020-12-02 EP claimed
US-10494518-B2 Anti-agglomerants for polyisobutylene production BASF SOUTH EAST ASIA PTE. LTD. (SG) 2019-12-03 US claimed
EP-3087137-B1 NOVEL ANTI-AGGLOMERANTS FOR POLYISOBUTYLENE PRODUCTION BASF SOUTH EAST ASIA PTE LTD (SG) 2019-09-18 EP claimed
US-10106656-B2 Anti-agglomerants for polyisobutylene production ARLANXEO Canada Inc. (CA) 2018-10-23 US claimed
US-20170158827-A1 ANTI-AGGLOMERANTS FOR POLYISOBUTYLENE PRODUCTION BASF SOUTH EAST ASIA PTE. LTD. (SG) 2017-06-08 US claimed
EP-3161069-A1 NOVEL ANTI-AGGLOMERANTS FOR POLYISOBUTYLENE PRODUCTION BASF South East Asia Pte. Ltd. (SG) 2017-05-03 EP claimed
US-20170029612-A1 NOVEL ANTI-AGGLOMERANTS FOR POLYISOBUTYLENE PRODUCTION BASF SOUTH EAST ASIA PTE. LTD. (SG) 2017-02-02 US claimed
EP-3087137-A1 NOVEL ANTI-AGGLOMERANTS FOR POLYISOBUTYLENE PRODUCTION BASF South East Asia Pte. Ltd. (SG) 2016-11-02 EP claimed
EP-3053992-A1 Biodiesel LANXESS Deutschland GmbH (DE) 2016-08-10 EP claimed
WO-2016000074-A1 NOVEL ANTI-AGGLOMERANTS FOR POLYISOBUTYLENE PRODUCTION LANXESS BUTYL PTE. LTD. (SG) 2016-01-07 WO claimed
WO-2015095960-A1 NOVEL ANTI-AGGLOMERANTS FOR POLYISOBUTYLENE PRODUCTION LANXESS BUTYL PTE. LTD. (SG) 2015-07-02 WO claimed
US-12319754-B2 Chlorinated copolymers and polymer products including chlorinated copolymer ARLANXEO SINGAPORE PTE. LTD. (SG) 2025-06-03 US disclosed
EP-0000354-A1 Mixtures that contain phosphonite, and polymers stabilized therewith CIBA-GEIGY AG (CH) 1979-01-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220257480-A1 AN ANTIPERSPIRANT COMPOSITION CUTA, TYR, DSG1 CA1 2286/4885CA2 3095/4885GABRA1 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.